Can a new pill help men last longer? a trial puts VV913 to the test

NCT ID NCT07722780

First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This trial tests whether an experimental drug called VV913 can help men with premature ejaculation last longer during intercourse. About 500 men aged 18 to 55 with diagnosed premature ejaculation will take either VV913 (at one of three doses) or a placebo pill before sex. Researchers will measure how long ejaculation is delayed using a stopwatch.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
an experimental drug called VV913
What this could lead to
If effective, VV913 could offer a new on-demand oral treatment for premature ejaculation, helping men gain better control.
What could go wrong
This is an early Phase 2 trial, so the drug may not work better than placebo. Side effects are still being evaluated.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREMATURE EJACULATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Peking University First Hospital

    Beijing, Beijing Municipality, 100034, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.